Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis.
Objective: Intranasal esketamine has been approved as an adjunctive therapy for treatment-resistant major depressive disorder with acute suicidal ideation and behavior. The authors conducted a systematic review and meta-analysis of the available data on its efficacy against depression and suicidalit...
| Publicado en: | American Journal of Psychiatry Vol. 182; no. 3; pp. 259 - 276 |
|---|---|
| Autores principales: | , , |
| Formato: | Artículo |
| Publicado: |
American Psychiatric Publishing, Inc.
Mar2025
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |